BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9443884)

  • 1. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?
    Heinecke JW; Lusis AJ
    Am J Hum Genet; 1998 Jan; 62(1):20-4. PubMed ID: 9443884
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation.
    Mackness B; Durrington PN; Mackness MI
    Lancet; 1999 Feb; 353(9151):468-9. PubMed ID: 9989726
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.
    Mackness MI; Arrol S; Mackness B; Durrington PN
    Lancet; 1997 Mar; 349(9055):851-2. PubMed ID: 9121268
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
    Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase and coronary heart disease.
    Mackness MI; Mackness B; Durrington PN; Fogelman AM; Berliner J; Lusis AJ; Navab M; Shih D; Fonarow GC
    Curr Opin Lipidol; 1998 Aug; 9(4):319-24. PubMed ID: 9739487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
    Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
    Mackness MI; Arrol S; Abbott C; Durrington PN
    Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paraoxonase gene family and coronary heart disease.
    Mackness B; Durrington PN; Mackness MI
    Curr Opin Lipidol; 2002 Aug; 13(4):357-62. PubMed ID: 12151850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis: cell biology and lipoproteins.
    Wahle KW
    Curr Opin Lipidol; 2002 Jun; 13(3):347-9. PubMed ID: 12045406
    [No Abstract]   [Full Text] [Related]  

  • 12. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
    J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase gene polymorphisms, oxidative stress, and diseases.
    Li HL; Liu DP; Liang CC
    J Mol Med (Berl); 2003 Dec; 81(12):766-79. PubMed ID: 14551701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
    Shih DM; Gu L; Hama S; Xia YR; Navab M; Fogelman AM; Lusis AJ
    J Clin Invest; 1996 Apr; 97(7):1630-9. PubMed ID: 8601628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.
    Mackness B; Durrington PN; Boulton AJ; Hine D; Mackness MI
    Eur J Clin Invest; 2002 Apr; 32(4):259-64. PubMed ID: 11952811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How high-density lipoprotein protects against the effects of lipid peroxidation.
    Mackness MI; Durrington PN; Mackness B
    Curr Opin Lipidol; 2000 Aug; 11(4):383-8. PubMed ID: 10945720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase genes and disease.
    Hegele RA
    Ann Med; 1999 Jun; 31(3):217-24. PubMed ID: 10442677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraoxonase, something more than an enzyme?].
    Canales A; Sánchez-Muniz FJ
    Med Clin (Barc); 2003 Oct; 121(14):537-48. PubMed ID: 14599410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.